中国科学院机构知识库网格
Chinese Academy of Sciences Institutional Repositories Grid
首页 机构 成果 学者
  
  1. CAS IR Grid
机构
采集方式
_filter
_filter
_filter
筛选

浏览/检索结果: 共7条，第1-7条 帮助

条数/页： 排序方式：
Identified potential pathogenic variants of BARD1 in 1449 Chinese high-risk breast cancer patients. 期刊论文  OAI收割
JOURNAL OF CLINICAL ONCOLOGY, 2022, 卷号: 40
作者:  Wang, Rong;  Ye, Weiwu;  Chen, Zhanhong;  Shao, Xiying
  |  收藏  |  浏览/下载：10/0  |  提交时间：2022/12/23
Apatinib combined with chemotherapy versus single chemotherapy in HER-2 negative advanced breast cancer: A randomized, controlled, open-label phase II study. 期刊论文  OAI收割
JOURNAL OF CLINICAL ONCOLOGY, 2022, 卷号: 40
作者:  Chen, Zhanhong;  Wang, Xiaojia;  Huang, Jian;  Zheng, Yabing;  Shao, Xiying
  |  收藏  |  浏览/下载：42/0  |  提交时间：2022/12/23
Development of a new HRD algorithm which was highly associated with anthracyclinecontaining neoadjuvant chemotherapy. 期刊论文  OAI收割
JOURNAL OF CLINICAL ONCOLOGY, 2022, 卷号: 40
作者:  Cao, Wen-Ming;  Pan, Jiani;  Wang, Xiaojia;  Lou, Feng;  Li, Mingwei
  |  收藏  |  浏览/下载：14/0  |  提交时间：2022/12/23
BRCANet: A deep hybrid network in predicting BRCA1/2 gene mutation of breast cancer with dynamic contrast-enhanced breast MRI. 期刊论文  OAI收割
JOURNAL OF CLINICAL ONCOLOGY, 2022, 卷号: 40
作者:  Cao, Wen-Ming;  Wang, Xiaojia;  Liu, Jian;  Wang, Lili;  Zhang, Xiaodong
  |  收藏  |  浏览/下载：47/0  |  提交时间：2022/12/23
Efficacy of everolimus-containing chemotherapy in HER2 negative metastatic breast cancer patients with PI3K/AKT/mTOR mutations: A retrospective study. 期刊论文  OAI收割
JOURNAL OF CLINICAL ONCOLOGY, 2021, 卷号: 39
作者:  Wang, Rong;  Wang, Xiaojia;  Chen, Zhan-Hong;  Niu, Jin;  Huang, Yuan
  |  收藏  |  浏览/下载：20/0  |  提交时间：2022/01/10
Ki67 and progesterone receptor status predicts sensitivity to palbociclib: a real-world study 期刊论文  OAI收割
ANNALS OF TRANSLATIONAL MEDICINE, 2021, 卷号: 9
作者:  Shao, Xiying;  Zheng, Yabing;  Cao, Wenming;  Shen, Xiabo;  Li, Guangliang
  |  收藏  |  浏览/下载：56/0  |  提交时间：2021/06/15
Primary analysis of OVERSTEP: A multicenter, randomized clinical trial of capecitabine or endocrine therapy as a maintenance therapy after the 1st-line chemotherapy in hormone receptor positive and HER2-negative advanced/metastatic breast cancer 期刊论文  OAI收割
CANCER RESEARCH, 2021, 卷号: 81
作者:  Huang, Jian;  Shao, Xiying
  |  收藏  |  浏览/下载：32/0  |  提交时间：2021/04/26